The impact of nanoparticle protein corona on cytotoxicity, immunotoxicity and target drug delivery

Claudia Corbo; Roberto Molinaro; Alessandro Parodi; Naama E. Toledano Furman; Francesco Salvatore; Ennio Tasciotti

doi:10.2217/nnm.15.188

The impact of nanoparticle protein corona on cytotoxicity, immunotoxicity and target drug delivery

Claudia Corbo, Roberto Molinaro, Alessandro Parodi, Naama E. Toledano Furman, Francesco Salvatore, Ennio Tasciotti

Research output: Contribution to journal › Review article › peer-review

485 Scopus citations

Abstract

In a perfect sequence of events, nanoparticles (NPs) are injected into the bloodstream where they circulate until they reach the target tissue. The ligand on the NP surface recognizes its specific receptor expressed on the target tissue and the drug is released in a controlled manner. However, once injected in a physiological environment, NPs interact with biological components and are surrounded by a protein corona (PC). This can trigger an immune response and affect NP toxicity and targeting capabilities. In this review, we provide a survey of recent findings on the NP-PC interactions and discuss how the PC can be used to modulate both cytotoxicity and the immune response as well as to improve the efficacy of targeted delivery of nanocarriers.

Original language	English (US)
Pages (from-to)	81-100
Number of pages	20
Journal	Nanomedicine
Volume	11
Issue number	1
DOIs	https://doi.org/10.2217/nnm.15.188
State	Published - Jan 2016

Keywords

immune response
nano-bio interface
nanomedicine
nanoparticles
protein corona
targeting
toxicity

ASJC Scopus subject areas

Bioengineering
Medicine (miscellaneous)
Biomedical Engineering
Materials Science(all)

Access to Document

10.2217/nnm.15.188

Cite this

@article{b0cafd60897f4e65b7595a54c6387e46,

title = "The impact of nanoparticle protein corona on cytotoxicity, immunotoxicity and target drug delivery",

abstract = "In a perfect sequence of events, nanoparticles (NPs) are injected into the bloodstream where they circulate until they reach the target tissue. The ligand on the NP surface recognizes its specific receptor expressed on the target tissue and the drug is released in a controlled manner. However, once injected in a physiological environment, NPs interact with biological components and are surrounded by a protein corona (PC). This can trigger an immune response and affect NP toxicity and targeting capabilities. In this review, we provide a survey of recent findings on the NP-PC interactions and discuss how the PC can be used to modulate both cytotoxicity and the immune response as well as to improve the efficacy of targeted delivery of nanocarriers.",

keywords = "immune response, nano-bio interface, nanomedicine, nanoparticles, protein corona, targeting, toxicity",

author = "Claudia Corbo and Roberto Molinaro and Alessandro Parodi and {Toledano Furman}, {Naama E.} and Francesco Salvatore and Ennio Tasciotti",

note = "Publisher Copyright: {\textcopyright} 2016 Future Medicine Ltd.",

year = "2016",

month = jan,

doi = "10.2217/nnm.15.188",

language = "English (US)",

volume = "11",

pages = "81--100",

journal = "Nanomedicine",

issn = "1743-5889",

publisher = "Future Medicine Ltd.",

number = "1",

}

TY - JOUR

T1 - The impact of nanoparticle protein corona on cytotoxicity, immunotoxicity and target drug delivery

AU - Corbo, Claudia

AU - Molinaro, Roberto

AU - Parodi, Alessandro

AU - Toledano Furman, Naama E.

AU - Salvatore, Francesco

AU - Tasciotti, Ennio

PY - 2016/1

Y1 - 2016/1

N2 - In a perfect sequence of events, nanoparticles (NPs) are injected into the bloodstream where they circulate until they reach the target tissue. The ligand on the NP surface recognizes its specific receptor expressed on the target tissue and the drug is released in a controlled manner. However, once injected in a physiological environment, NPs interact with biological components and are surrounded by a protein corona (PC). This can trigger an immune response and affect NP toxicity and targeting capabilities. In this review, we provide a survey of recent findings on the NP-PC interactions and discuss how the PC can be used to modulate both cytotoxicity and the immune response as well as to improve the efficacy of targeted delivery of nanocarriers.

AB - In a perfect sequence of events, nanoparticles (NPs) are injected into the bloodstream where they circulate until they reach the target tissue. The ligand on the NP surface recognizes its specific receptor expressed on the target tissue and the drug is released in a controlled manner. However, once injected in a physiological environment, NPs interact with biological components and are surrounded by a protein corona (PC). This can trigger an immune response and affect NP toxicity and targeting capabilities. In this review, we provide a survey of recent findings on the NP-PC interactions and discuss how the PC can be used to modulate both cytotoxicity and the immune response as well as to improve the efficacy of targeted delivery of nanocarriers.

KW - immune response

KW - nano-bio interface

KW - nanomedicine

KW - nanoparticles

KW - protein corona

KW - targeting

KW - toxicity

UR - http://www.scopus.com/inward/record.url?scp=84950255947&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84950255947&partnerID=8YFLogxK

U2 - 10.2217/nnm.15.188

DO - 10.2217/nnm.15.188

M3 - Review article

C2 - 26653875

AN - SCOPUS:84950255947

SN - 1743-5889

VL - 11

SP - 81

EP - 100

JO - Nanomedicine

JF - Nanomedicine

IS - 1

ER -

The impact of nanoparticle protein corona on cytotoxicity, immunotoxicity and target drug delivery

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this